Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation.

作者信息

Langrehr J M, Schneller A, Guckelberger O, Lohmann R, Neumann U, Jonas S, Klupp J, Settmacher U, Knoop M, Bechstein W O, Neuhaus P J

机构信息

Department of Surgery, Virchow-Klinikum, Humboldt University Berlin, Germany.

出版信息

Transplant Proc. 1998 Jun;30(4):1439-40. doi: 10.1016/s0041-1345(98)00306-6.

DOI:10.1016/s0041-1345(98)00306-6

PMID:9636583

Abstract

摘要

相似文献

Comparison of quadruple induction including ATG or IL-2R antibody with FK506-based therapy after liver transplantation.

Transplant Proc. 1998 Jun;30(4):1439-40. doi: 10.1016/s0041-1345(98)00306-6.

Chronic rejection after orthotopic liver transplantation is increased under induction therapy with interleukin-2 receptor antibody BT563.在使用白细胞介素-2受体抗体BT563进行诱导治疗的情况下，原位肝移植后的慢性排斥反应会增加。

Transplant Proc. 2001 May;33(3):2290-1. doi: 10.1016/s0041-1345(01)01993-5.

IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation.

Transplant Proc. 2001 Feb-Mar;33(1-2):1433-4. doi: 10.1016/s0041-1345(00)02541-0.

Interleukin-2 receptor antibody versus antithymocyte globulin as part of quadruple induction therapy after orthotopic liver transplantation: a randomized study.

Transplant Proc. 1996 Dec;28(6):3204.

Quadruple induction therapy including antithymocyte globulin or interleukin-2 receptor antibody or FK 506-based induction therapy after liver transplantation.肝移植后采用包括抗胸腺细胞球蛋白或白细胞介素-2受体抗体或基于FK 506的诱导治疗的四联诱导疗法。

Transplant Proc. 1999 Feb-Mar;31(1-2):380. doi: 10.1016/s0041-1345(98)01670-4.

Quadruple induction immunosuppression after liver transplantation with IL-2 receptor antibody (BT 563) is equally effective and better tolerated than ATG induction therapy.肝移植后使用白细胞介素-2受体抗体（BT 563）进行四联诱导免疫抑制与抗胸腺细胞球蛋白诱导治疗同样有效且耐受性更好。

Transplant Proc. 1993 Feb;25(1 Pt 1):587-9.

Selective immunosuppression with FK 506, anti-IL-2R, and anti-ICAM-1 monoclonal antibodies: contrasting effects after liver and small bowel transplantation in rats.

Transplant Proc. 1998 Aug;30(5):2161-2. doi: 10.1016/s0041-1345(98)00573-9.

Quadruple induction immunosuppression after liver transplantation with interleukin-2 receptor antibody (BT 563) is equally effective and better tolerated than antithymocyte globulin induction therapy.肝移植后使用白细胞介素-2受体抗体（BT 563）进行四联诱导免疫抑制与抗胸腺细胞球蛋白诱导疗法同样有效且耐受性更好。

Transplant Proc. 1993 Apr;25(2):1940-1.

Quadruple immunosuppression including a new IL-2-receptor antibody and the incidence of infections after liver transplantation.包括新型白细胞介素-2受体抗体在内的四联免疫抑制与肝移植术后感染发生率

Transpl Int. 1992;5 Suppl 1:S168-9. doi: 10.1007/978-3-642-77423-2_52.

Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.肝移植后白细胞介素-2受体抗体与抗胸腺细胞球蛋白用于诱导免疫抑制：一项前瞻性随机试验的初步结果

Transplant Proc. 1995 Feb;27(1):1140-1.

引用本文的文献

Antibody induction versus corticosteroid induction for liver transplant recipients.肝移植受者的抗体诱导与皮质类固醇诱导

Cochrane Database Syst Rev. 2014 May 31;2014(5):CD010252. doi: 10.1002/14651858.CD010252.pub2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验